Medtronic has announced the results from a retrospective study of its Aquamantys system that demonstrated the efficacy in limiting blood loss and reducing transfusions during spinal corrective surgery.

The Aquamantys 2.3 bipolar sealer utilises Transcollation technology, a proprietary combination of radiofrequency (RF) energy and saline, to facilitate hemostatic sealing of soft tissue and bone during surgery.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The study, supported in part by Salient Surgical Technologies, involved 176 consecutive corrective spinal surgeries for adolescent idiopathic scoliosis – 100 using the Aquamantys 2.3 bipolar sealer and 76 without the Aquamantys sealer.

It found that with the use of the Aquamantys 2.3 bipolar sealer, estimated blood loss (EBL) was reduced by 57% and estimated blood loss per level fused by 59%.